AMN Healthcare Services, Inc. Financial Ratios — AMN Stock

Profitability	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	173.43	66.04	33.18	16.23	51.66	43.56	15.64	-10.66
Return on Assets (%)	-10.93	-4.79	3.25	5.87	5.17	10.49	10.24	10.86	10.32	6.66	3.3	11.94	14.75	7.25	-5.5
Return on Capital (%)	- -	55.7	-48.89	-56.94	-112.18	163.84	46.43	34.96	25.89	14.68	9.04	22.82	25.15	10.23	- -
Return on Invested Capital (%)	- -	3.81	9.44	10.94	9.8	17.94	16.94	17.46	15.86	10.76	7.15	18.5	24.19	12.47	- -
Gross Margin (%)	27.52	28.09	28.34	29.38	30.51	32.08	32.58	32.41	32.6	33.46	33.08	32.87	32.74	32.98	30.81
EBITDA Margin (%)	3.3	6.09	7.08	7.81	8.1	10.24	11.63	12.31	11.43	10.6	10.17	14.6	14.96	13.18	9.84
Operating Margin (%)	1.05	4.24	5.59	6.47	6.55	8.81	10.07	10.68	9.5	7.96	6.24	12	12.34	8.93	4.01
Incremental Operating Margin (%)	29.28	14.06	23.61	21.01	9.92	14.28	14.29	24.13	-6.51	-30.12	-16.11	20.67	13.43	21.23	27.14
Pretax Margin (%)	-9.48	1.57	2.86	5.52	5.66	8.28	9.26	9.69	8.74	6.68	3.82	11.14	11.57	7.5	-5.78
Profit Margin (%)	-7.76	-2.96	1.8	3.25	3.21	5.6	5.56	6.67	6.64	5.13	2.95	8.22	8.47	5.56	-4.93
Net Income to Common Margin (%)	-7.76	-2.96	1.8	3.25	3.21	5.6	5.56	6.67	6.64	5.13	2.95	8.22	8.47	5.56	-4.93
Effective Tax Rate (%)	- -	63.97	40.3	41.02	43.38	32.37	39.92	31.23	24.07	23.23	22.79	26.25	26.81	25.89	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	173.43	66.04	33.18	16.23	51.66	43.56	15.64	-10.66

Credit	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Total Debt	219	209	158	159	161	218	363	320	441	722	955	867	861	1,350	1,098
ST Debt	18	35	- -	10	26	38	4	- -	- -	14	20	11	8	8	6
LT Debt	201	174	158	149	136	181	359	320	441	708	936	856	853	1,342	1,092
Total Debt/EBITDA	9.9	3.86	2.34	2.01	1.92	1.46	1.64	1.31	1.81	3.07	3.92	1.49	1.1	2.7	3.74
Net Debt/EBITDA	9.81	3.79	2.26	1.81	1.77	1.39	1.59	1.25	1.75	2.27	3.42	1.14	0.99	2.55	3.56
Total Debt/EBIT	31.06	5.55	2.97	2.42	2.37	1.7	1.89	1.51	2.17	4.08	6.4	1.81	1.33	3.99	9.16
Net Debt/EBIT	30.8	5.44	2.86	2.18	2.18	1.62	1.84	1.43	2.1	3.02	5.58	1.38	1.2	3.76	8.73
EBITDA to Interest Expense	1.12	2.28	2.59	8.18	9.08	19.23	14.31	12.44	15.12	8.28	4.22	17.07	19.41	9.22	4.2
EBITDA-CapEx/Interest Expense	0.91	2.08	2.38	7.24	7.01	15.77	12.89	11.09	12.86	7	3.54	15.5	17.41	7.28	3.04
EBIT to Interest Expense	0.36	1.59	2.05	6.78	7.35	16.54	12.39	10.8	12.56	6.22	2.59	14.03	16.02	6.25	1.71
Interest Expense	20	24	26	10	9	8	15	20	16	28	58	34	40	54	70
Common Equity/Total Assets	-41.39	-48.34	-46.72	-34.89	-26.09	-10.87	0.86	11.38	19.2	20.74	19.97	25.46	42.98	49.66	54.03
Long-Term Debt/Equity (%)	130.86	128.41	86.86	68.28	52.88	52.03	79.93	56.86	68.95	96.15	114.16	73.64	81.72	161.48	154.48
Long-Term Debt/Capital (%)	-1,484.74	-347.78	-189.3	-285.12	-827.28	147.39	96.27	69.15	60.59	63.09	65.64	51.41	40.57	47.9	45.43
Long-Term Debt/Total Assets (%)	35.72	32.52	30.57	24.6	19.93	20.56	30.26	25.51	29.52	36.67	39.76	27.32	29.53	45.9	45.19
Total Debt/Equity (%)	142.81	153.94	86.86	72.87	62.82	62.81	80.76	56.86	68.95	98.04	116.57	74.62	82.5	162.44	155.36
Total Debt/Capital (%)	-1,620.33	-416.94	-189.3	-304.3	-982.75	177.92	97.28	69.15	60.59	64.33	67.03	52.09	40.95	48.18	45.68
Total Debt/Total Assets (%)	38.99	38.99	30.57	26.26	23.68	24.82	30.58	25.51	29.52	37.39	40.6	27.69	29.81	46.17	45.44
Net Debt to Equity	141.58	151.02	83.74	65.72	57.73	60.06	78.4	54.17	66.79	72.5	101.68	56.92	74.64	152.99	147.92
Net Debt/Capital (%)	-1,410.09	-379.05	-170.88	-211.29	-502.52	184.51	97.2	68.1	59.83	51.37	59.69	44.58	38.22	45.92	43.69
EBITDA	22	54	67	79	84	150	221	245	244	235	243	582	784	499	294
EBITDA-CapEx	18	49	62	70	65	123	199	218	208	199	204	528	703	394	213
Operating Income (Loss)	7	38	53	66	68	129	192	212	203	177	149	478	647	338	120

Liquidity	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Cash Ratio	0.02	0.03	0.05	0.11	0.07	0.04	0.04	0.06	0.05	0.22	0.07	0.19	0.08	0.05	0.02
Current Ratio	1.52	1.52	1.86	1.63	1.59	1.5	1.64	1.79	1.57	1.48	1.26	1.39	1.27	1.28	1.09
Quick Ratio	1.27	1.26	1.52	1.29	1.3	1.36	1.46	1.59	1.4	1.36	1.13	1.25	1.19	1.19	0.97
CFO/Avg Current Liab	0.09	0.15	0.47	0.48	0.17	0.26	0.51	0.59	0.79	0.66	0.64	0.44	0.72	0.49	0.53
Common Equity/Total Assets	-41.39	-48.34	-46.72	-34.89	-26.09	-10.87	0.86	11.38	19.2	20.74	19.97	25.46	42.98	49.66	54.03
Long-Term Debt/Equity (%)	130.86	128.41	86.86	68.28	52.88	52.03	79.93	56.86	68.95	96.15	114.16	73.64	81.72	161.48	154.48
Long-Term Debt/Capital (%)	-1,484.74	-347.78	-189.3	-285.12	-827.28	147.39	96.27	69.15	60.59	63.09	65.64	51.41	40.57	47.9	45.43
Long-Term Debt/Total Assets (%)	35.72	32.52	30.57	24.6	19.93	20.56	30.26	25.51	29.52	36.67	39.76	27.32	29.53	45.9	45.19
Total Debt/Equity (%)	142.81	153.94	86.86	72.87	62.82	62.81	80.76	56.86	68.95	98.04	116.57	74.62	82.5	162.44	155.36
Total Debt/Capital (%)	-1,620.33	-416.94	-189.3	-304.3	-982.75	177.92	97.28	69.15	60.59	64.33	67.03	52.09	40.95	48.18	45.68
Total Debt/Total Assets (%)	38.99	38.99	30.57	26.26	23.68	24.82	30.58	25.51	29.52	37.39	40.6	27.69	29.81	46.17	45.44
CFO/Total Liabilities	1.98	4.83	17.41	15.57	6.53	10.57	18.16	23.22	26.59	18.82	16.74	15.5	35.44	17.78	18.75
CFO/CapEx	1.94	4.15	10.67	6.65	1.45	2.08	6.1	6.05	6.24	6.17	6.57	5.69	8.08	3.53	3.96
Altman's Z-Score	2.13	3	4.38	4.41	4.33	5.46	6.1	6.62	6.58	5.28	5.24	5.91	7.86	6.19	4.95

Working Capital	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Accounts Receivable Turnover	5.72	5.66	5.78	6.19	5.45	5.38	5.28	5.08	5.29	5.28	5.47	5.39	5.31	4.5	4.78
Days Sales Outstanding	63.76	64.51	63.16	58.93	67.02	67.8	69.08	71.84	68.99	69.1	66.75	67.74	68.68	81.18	76.42
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	29.66	20.67	15.75	13.78	11.72	13.39	15.06	16.95	18.5	15.99	15.26	11.98	9.9	9.23	14.85
Accounts Payable Turnover Days	12.3	17.66	23.17	26.49	31.14	27.26	24.23	21.53	19.73	22.83	23.92	30.46	36.86	39.55	24.58
Cash Conversion Cycle	51.45	46.85	39.99	32.45	35.88	40.53	44.84	50.31	49.26	46.27	42.82	37.28	31.82	41.63	51.85
Inventory to Cash Days	63.76	64.51	63.16	58.93	67.02	67.8	69.08	71.84	68.99	69.1	66.75	67.74	68.68	81.18	76.42
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Market Capitalization	214	177	481	676	911	1,476	1,844	2,354	2,684	2,910	3,237	5,833	4,585	2,933	913
- Cash & Cash Equivalents	2	4	6	16	13	10	11	15	14	83	29	181	65	33	11
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	219	209	158	159	161	218	363	320	441	722	955	867	861	1,350	1,098
Enterprise Value	431	382	633	819	1,060	1,685	2,196	2,659	3,111	3,549	4,163	6,519	5,381	4,251	2,001
Total Capital	-14	-50	-84	-52	-16	123	373	463	727	1,123	1,426	1,665	2,102	2,802	2,403
Total Debt/Capital (%)	-1,620.33	-416.94	-189.3	-304.3	-982.75	177.92	97.28	69.15	60.59	64.33	67.03	52.09	40.95	48.18	45.68
Total Debt / EV	0.51	0.55	0.25	0.19	0.15	0.13	0.17	0.12	0.14	0.2	0.23	0.13	0.16	0.32	0.55
EV/Sales	0.64	0.43	0.66	0.81	1.02	1.15	1.15	1.34	1.46	1.6	1.74	1.64	1.03	1.12	0.67
EV/EBITDA	19.48	7.06	9.38	10.36	12.63	11.24	9.92	10.87	12.75	15.08	17.1	11.21	6.86	8.51	6.81
EV/EBIT	61.12	10.14	11.87	12.5	15.6	13.07	11.46	12.52	15.34	20.06	27.89	13.64	8.32	12.56	16.7
EV/Cash Flow to Firm	17.6	13.7	8.57	12.43	32.2	27.36	15.33	15.28	13	14.39	13.81	19.73	7.88	10.31	5.27
EV/Free Cash Flow to Firm	15.04	11.74	7.98	10.93	20.36	19.02	13.3	13.26	11.29	12.54	12.23	16.97	7.04	8.21	4.34
Diluted Market Cap	214	204	539	702	942	1,517	1,894	2,434	2,758	2,966	3,255	5,877	4,614	2,946	913
Diluted Enterprise Value	431	408	692	846	1,091	1,725	2,247	2,739	3,184	3,605	4,181	6,563	5,410	4,263	2,001
EV per Share	12.38	9.56	15.21	17.81	22.79	35.45	45.8	55.62	65.67	76	87.78	136.72	120.68	108.51	52.39
TTM Sales	670	887	954	1,012	1,036	1,463	1,902	1,988	2,136	2,222	2,394	3,984	5,243	3,789	2,984
TTM EBITDA	22	54	67	79	84	150	221	245	244	235	243	582	784	499	294
TTM Operating Income	7	38	53	66	68	129	192	212	203	177	149	478	647	338	120
TTM Cash Flow to Firm	24	28	74	66	33	62	143	174	239	247	301	330	683	412	380
TTM Free Cash Flow to Firm	29	33	79	75	52	89	165	201	276	283	341	384	764	518	461

Multiples	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Price/Earnings	- -	- -	28.06	20.52	27.44	18.02	17.42	17.76	18.94	25.53	45.8	17.82	10.33	13.92	- -
Price/Earnings Average	-4.81	-9.87	17.8	19.4	20.24	15.92	15.63	14.55	19.01	22.61	39.25	13.81	10.74	16.51	-13.52
Price/Earnings High	-57.13	-130.73	29.57	22.61	28.46	21.75	20.38	18.66	22.79	26.96	59.88	18.81	12.96	21.17	-20.84
Price/Earnings Low	-37.14	-5.65	9.38	14.43	14.49	10.4	9.62	12.12	15.72	18.45	24.6	9.82	8.31	10.75	-5.84
Price/Book Value	-0.92	-0.68	-1.99	-3.2	-5.13	-15.42	181.59	16.5	9.37	7.27	6.89	7.32	3.69	2.02	0.7
Price/Book Value Average	-1.08	-1	-1.26	-3.03	-3.78	-13.63	162.96	13.51	9.4	6.43	5.9	5.67	3.84	2.4	1.52
Price/Book Value High	-12.77	-13.26	-2.1	-3.53	-5.32	-18.61	212.48	17.34	11.27	7.67	9	7.72	4.63	3.07	2.35
Price/Book Value Low	-8.3	-0.57	-0.66	-2.25	-2.71	-8.9	100.31	11.26	7.78	5.25	3.7	4.03	2.97	1.56	0.66
Price/Tangible Book Value	-1.29	-1.35	-6.16	-8.76	-18.11	-46.27	-13.35	-455.86	-21.36	-11.31	-5.31	-23.83	-12.44	-3.89	-1.6
Price/Tangible Book Value Average	-1.5	-1.98	-3.9	-8.28	-13.36	-40.89	-11.98	-373.31	-21.44	-10.02	-4.55	-18.47	-12.94	-4.61	-3.47
Price/Tangible Book Value High	-17.86	-26.16	-6.49	-9.66	-18.79	-55.84	-15.62	-479	-25.71	-11.95	-6.94	-25.15	-15.61	-5.91	-5.35
Price/Tangible Book Value Low	-11.61	-1.13	-2.06	-6.16	-9.56	-26.71	-7.37	-311.09	-17.74	-8.18	-2.85	-13.13	-10.01	-3	-1.5
Price/Sales	0.32	0.2	0.5	0.67	0.88	1.01	0.97	1.18	1.26	1.31	1.35	1.46	0.87	0.77	0.31
Price/Sales Average	0.37	0.29	0.32	0.63	0.65	0.89	0.87	0.97	1.26	1.16	1.16	1.13	0.91	0.92	0.67
Price/Sales High	4.43	3.87	0.53	0.74	0.91	1.22	1.13	1.24	1.51	1.38	1.77	1.55	1.1	1.18	1.03
Price/Sales Low	2.88	0.17	0.17	0.47	0.46	0.58	0.54	0.81	1.04	0.95	0.73	0.81	0.7	0.6	0.29
Price/Cash Flow	26.45	9.16	8.24	11.23	32.93	26.2	13.77	14.67	11.82	12.94	12.6	19.1	7.01	7.88	2.85
Price/Cash Flow Average	30.93	13.42	5.22	10.62	24.29	23.16	12.35	12.01	11.87	11.46	10.8	14.81	7.3	9.35	6.2
Price/Cash Flow High	367.18	177.8	8.68	12.38	34.16	31.62	16.11	15.41	14.23	13.67	16.47	20.16	8.8	11.98	9.56
Price/Cash Flow Low	238.7	7.69	2.75	7.9	17.39	15.12	7.6	10.01	9.82	9.36	6.77	10.53	5.64	6.08	2.68
Price/Free Cash Flow	17.45	8.5	8.45	10.15	20.13	18.2	12.15	13.02	10.47	11.35	11	16.37	6.28	6.17	2.28
Price/Free Cash Flow Average	20.41	12.45	5.36	9.59	14.85	16.08	10.91	10.66	10.51	10.05	9.43	12.69	6.53	7.31	4.95
Price/Free Cash Flow High	242.32	164.99	8.9	11.18	20.88	21.96	14.22	13.68	12.6	11.98	14.38	17.28	7.88	9.38	7.63
Price/Free Cash Flow Low	157.53	7.13	2.82	7.14	10.63	10.5	6.71	8.88	8.69	8.2	5.91	9.02	5.05	4.76	2.14
EV/Sales	0.64	0.43	0.66	0.81	1.02	1.15	1.15	1.34	1.46	1.6	1.74	1.64	1.03	1.12	0.67
EV/Sales Average	0.7	0.52	0.48	0.77	0.79	1.03	1.05	1.12	1.46	1.45	1.55	1.31	1.06	1.27	1.03
EV/Sales High	4.76	4.1	0.69	0.88	1.06	1.36	1.32	1.4	1.71	1.67	2.15	1.72	1.25	1.52	1.39
EV/Sales Low	3.21	0.4	0.33	0.61	0.61	0.72	0.72	0.96	1.24	1.23	1.11	0.98	0.86	0.95	0.65
EV/EBITDA	19.48	7.06	9.38	10.36	12.63	11.24	9.92	10.87	12.75	15.08	17.1	11.21	6.86	8.51	6.81
EV/EBITDA Average	21.12	8.58	6.78	9.89	9.78	10.1	9.07	9.12	12.79	13.66	15.2	8.95	7.1	9.6	10.47
EV/EBITDA High	143.97	67.3	9.77	11.23	13.03	13.28	11.34	11.35	14.99	15.77	21.18	11.76	8.35	11.57	14.14
EV/EBITDA Low	97.03	6.54	4.64	7.82	7.5	7.08	6.2	7.81	10.88	11.65	10.94	6.7	5.72	7.17	6.63
EV/EBIT	61.12	10.14	11.87	12.5	15.6	13.07	11.46	12.52	15.34	20.06	27.89	13.64	8.32	12.56	16.7
EV/EBIT Average	66.26	12.33	8.58	11.94	12.08	11.74	10.47	10.51	15.39	18.18	24.79	10.89	8.6	14.17	25.66
EV/EBIT High	451.79	96.65	12.36	13.55	16.1	15.44	13.09	13.08	18.03	20.99	34.55	14.32	10.12	17.07	34.65
EV/EBIT Low	304.48	9.39	5.87	9.44	9.27	8.23	7.15	9	13.09	15.5	17.85	8.16	6.93	10.58	16.24
Last Price	6.14	4.43	11.55	14.7	19.6	31.05	38.45	49.25	56.66	62.31	68.25	122.33	102.82	74.88	23.92
High Price	85.25	86.03	12.17	16.2	20.33	37.47	44.99	51.75	68.2	65.81	89.22	129.12	129.04	113.85	80.22
Low Price	55.42	3.72	3.86	10.34	10.35	17.92	21.24	33.61	47.05	45.04	36.65	67.4	82.76	57.8	22.47
Enterprise Value	431	382	633	819	1,060	1,685	2,196	2,659	3,111	3,549	4,163	6,519	5,381	4,251	2,001
Enterprise Value Average	467	464	457	782	820	1,513	2,007	2,233	3,121	3,216	3,700	5,207	5,566	4,795	3,074
Enterprise Value High	3,187	3,639	659	888	1,094	1,990	2,509	2,779	3,657	3,713	5,157	6,843	6,550	5,777	4,151
Enterprise Value Low	2,148	353	313	618	629	1,061	1,371	1,911	2,656	2,743	2,664	3,900	4,487	3,582	1,945

Per Share Data Items	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Shares Outstanding	39	40	46	46	47	48	48	47	47	47	47	47	42	38	38
Diluted Weighted Avg Shares	35	46	47	48	48	49	49	49	49	48	48	48	45	39	38
Basic Weighted Avg Shares	35	40	42	46	47	48	48	48	47	47	47	48	45	39	38
Revenue per Share	19.23	22.24	22.91	22.01	22.28	30.79	39.67	41.59	45.09	47.58	50.47	83.55	117.59	96.73	78.13
EBITDA per Share	0.64	1.35	1.62	1.72	1.8	3.15	4.61	5.12	5.15	5.04	5.13	12.2	17.59	12.75	7.69
Operating Income per Share	0.2	0.94	1.28	1.43	1.46	2.71	4	4.44	4.28	3.79	3.15	10.02	14.51	8.64	3.14
Basic EPS, GAAP	-1.49	-0.66	0.41	0.72	0.71	1.72	2.21	2.77	2.99	2.44	1.49	6.87	9.96	5.38	-3.85
Basic EPS from Cont Ops	-1.51	0.13	0.39	0.72	0.71	1.72	2.21	2.77	2.99	2.44	1.49	6.87	9.96	5.38	-3.85
Diluted EPS, GAAP	-1.49	-0.57	0.37	0.69	0.69	1.68	2.15	2.68	2.91	2.4	1.48	6.81	9.9	5.36	-3.85
Diluted EPS from Cont Ops	-1.51	0.11	0.35	0.69	0.69	1.68	2.15	2.68	2.91	2.4	1.48	6.81	9.9	5.36	-3.85
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.23	0.48	1.4	1.31	0.6	1.18	2.79	3.36	4.79	4.81	5.42	6.4	14.66	9.5	8.39
Free Cash Flow per Basic Share	0.11	0.37	1.27	1.11	0.18	0.62	2.33	2.8	4.02	4.03	4.59	5.28	12.85	6.81	6.27
Cash & Equivalents per Share	0.05	0.1	0.14	0.34	0.28	0.2	0.22	0.32	0.29	1.78	0.62	3.79	1.45	0.84	0.28
Book Value per Share	-6.68	-6.49	-5.81	-4.59	-3.82	-2.01	0.21	2.99	6.05	8.58	9.91	16.72	27.84	37.07	34.18
Tangible Book Value per Share	-4.77	-3.29	-1.88	-1.68	-1.08	-0.67	-2.88	-0.11	-2.65	-5.51	-12.86	-5.13	-8.27	-19.26	-14.98

AMN Healthcare Services, Inc.

Profitability

Credit

Liquidity

Working Capital

Enterprise Value

Multiples

Per Share Data Items